Medical Trials Need More Diversity
According to the National Cancer Institute, African-Americans account for less than 10 percent of its clinical trial participants. That's despite being more likely than any other racial group to die of cancer. Host Michel Martin talks with Junius Hayes. He volunteered to be the first American participant to test a prostate cancer device.